GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Livzon Pharmaceutical Group Inc (SZSE:000513) » Definitions » Cyclically Adjusted Revenue per Share

Livzon Pharmaceutical Group (SZSE:000513) Cyclically Adjusted Revenue per Share : ¥11.08 (As of Mar. 2024)


View and export this data going back to 1993. Start your Free Trial

What is Livzon Pharmaceutical Group Cyclically Adjusted Revenue per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

Livzon Pharmaceutical Group's adjusted revenue per share for the three months ended in Mar. 2024 was ¥3.468. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is ¥11.08 for the trailing ten years ended in Mar. 2024.

During the past 12 months, Livzon Pharmaceutical Group's average Cyclically Adjusted Revenue Growth Rate was 6.40% per year. During the past 3 years, the average Cyclically Adjusted Revenue Growth Rate was 9.40% per year. During the past 5 years, the average Cyclically Adjusted Revenue Growth Rate was 10.30% per year. During the past 10 years, the average Cyclically Adjusted Revenue Growth Rate was 12.50% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Revenue Growth Rate of Livzon Pharmaceutical Group was 14.80% per year. The lowest was 3.90% per year. And the median was 10.90% per year.

As of today (2024-05-26), Livzon Pharmaceutical Group's current stock price is ¥38.68. Livzon Pharmaceutical Group's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2024 was ¥11.08. Livzon Pharmaceutical Group's Cyclically Adjusted PS Ratio of today is 3.49.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Livzon Pharmaceutical Group was 8.31. The lowest was 2.89. And the median was 4.54.


Livzon Pharmaceutical Group Cyclically Adjusted Revenue per Share Historical Data

The historical data trend for Livzon Pharmaceutical Group's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Livzon Pharmaceutical Group Cyclically Adjusted Revenue per Share Chart

Livzon Pharmaceutical Group Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 7.58 8.30 9.25 10.20 10.86

Livzon Pharmaceutical Group Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 10.41 10.56 10.80 10.86 11.08

Competitive Comparison of Livzon Pharmaceutical Group's Cyclically Adjusted Revenue per Share

For the Drug Manufacturers - Specialty & Generic subindustry, Livzon Pharmaceutical Group's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Livzon Pharmaceutical Group's Cyclically Adjusted PS Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Livzon Pharmaceutical Group's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Livzon Pharmaceutical Group's Cyclically Adjusted PS Ratio falls into.



Livzon Pharmaceutical Group Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Livzon Pharmaceutical Group's adjusted Revenue per Share data for the three months ended in Mar. 2024 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=3.468/115.2271*115.2271
=3.468

Current CPI (Mar. 2024) = 115.2271.

Livzon Pharmaceutical Group Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201406 1.662 98.200 1.950
201409 1.744 98.900 2.032
201412 1.680 99.000 1.955
201503 1.858 99.900 2.143
201506 1.805 99.500 2.090
201509 2.034 100.500 2.332
201512 2.043 100.600 2.340
201603 2.037 102.200 2.297
201606 2.302 101.400 2.616
201609 2.287 102.400 2.573
201612 2.061 102.600 2.315
201703 2.287 103.200 2.554
201706 2.237 103.100 2.500
201709 2.411 104.100 2.669
201712 2.164 104.500 2.386
201803 2.518 105.300 2.755
201806 2.360 104.900 2.592
201809 2.449 106.600 2.647
201812 2.150 106.500 2.326
201903 2.788 107.700 2.983
201906 2.492 107.700 2.666
201909 2.505 109.800 2.629
201912 2.226 111.200 2.307
202003 2.697 112.300 2.767
202006 2.729 110.400 2.848
202009 2.988 111.700 3.082
202012 2.752 111.500 2.844
202103 3.545 112.662 3.626
202106 3.083 111.769 3.178
202109 3.307 112.215 3.396
202112 2.908 113.108 2.962
202203 3.710 114.335 3.739
202206 3.038 114.558 3.056
202209 3.387 115.339 3.384
202212 3.355 115.116 3.358
202303 3.636 115.116 3.640
202306 3.556 114.558 3.577
202309 3.176 115.339 3.173
202312 2.991 114.781 3.003
202403 3.468 115.227 3.468

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.


Livzon Pharmaceutical Group  (SZSE:000513) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Livzon Pharmaceutical Group's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=38.68/11.08
=3.49

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Livzon Pharmaceutical Group was 8.31. The lowest was 2.89. And the median was 4.54.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


Livzon Pharmaceutical Group Cyclically Adjusted Revenue per Share Related Terms

Thank you for viewing the detailed overview of Livzon Pharmaceutical Group's Cyclically Adjusted Revenue per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Livzon Pharmaceutical Group (SZSE:000513) Business Description

Traded in Other Exchanges
Address
38 Chuangye North Road, Headquarters Building, Jinwan District, Guangdong Province, Zhuhai, CHN, 519090
Livzon Pharmaceutical Group Inc is engaged in China's healthcare sector. As a pharmaceutical manufacturer, the company's portfolio comprises Western pharmaceutical preparations, bulk drugs, traditional Chinese medicines, as well as diagnostic reagents and equipment. Its drug address serious conditions such as gastrointestinal, cardiovascular, anti-infectious, antimicrobial, antineoplastic, hemopoietic system, and other conditions. It distributes its products within domestic markets and to overseas markets. It operates in a single reportable segment which is pharmaceutical manufacturing.
Executives
Xu Guo Xiang Directors, executives
Tang Yang Gang Directors, executives
Yang Liang Secretary Dong
Si Yan Xia Executives
Zhou Peng Executives
Huang Yu Xuan Executives
Huang Hua Min Supervisors
Yang Dai Hong Executives
Wang Wu Ping Executives

Livzon Pharmaceutical Group (SZSE:000513) Headlines

No Headlines